HeartSciences Income Statement (2021-2026) | HSCS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Dec2025 Apr2026
Revenue & cost
Revenue (Quarter) 0.01M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M0.00M
Cost of Revenue (Quarter) 0.01M854.000.00M0.00M760.000.00M0.00M0.00M760.000.00M
Gross Profit (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M0.00M
Operating items
Research & Development (Quarter) 0.40M0.55M0.70M1.36M0.43M0.85M0.64M0.53M0.57M0.76M0.51M1.05M1.22M1.20M1.03M0.93M1.00M0.73M0.48M
Selling, General & Administrative (Quarter) 0.28M0.41M0.40M0.63M1.00M0.93M0.67M1.06M0.77M0.82M1.03M0.83M0.85M0.79M1.34M0.99M0.88M1.35M2.06M
Operating Expenses (Quarter) 0.68M0.96M1.10M1.98M1.43M1.77M1.31M1.60M1.33M1.57M1.54M1.88M2.08M1.99M2.37M1.92M1.88M2.07M2.54M
Operating Income (Quarter) -0.67M-0.96M-1.10M-1.98M-1.43M-1.77M-1.31M-1.60M-1.33M-1.57M-1.53M-1.88M-2.08M-1.99M-2.37M-1.92M-1.87M-2.07M-2.54M
EBIT (Quarter) -0.67M-0.96M-1.10M-1.98M-1.43M-1.77M-1.31M-1.60M-1.33M-1.57M-1.53M-1.88M-2.08M-1.99M-2.37M-1.92M-1.87M-2.07M-2.54M
Non-operating items
Other Non Operating Income (Quarter) 0.25M851.00401.000.00M255.0060.003.0016.000.05M0.05M0.02M0.01M0.01M0.00M0.00M0.01M
Non Operating Income (Quarter) 0.17M-0.08M-0.14M-0.08M-0.14M-0.03M-0.03M-0.03M-0.04M-0.18M-0.12M0.03M0.02M-0.10M-0.16M-0.17M-0.18M-0.28M-0.21M
Net income details
EBT (Quarter) -0.75M-1.03M-1.24M-2.05M-11.85M-12.54M-12.43M-1.63M-13.35M-13.95M-14.30M-1.90M-15.68M-16.05M-16.96M-2.10M-17.34M-2.35M-2.76M
Profit After Tax (Quarter) -0.50M-1.03M-1.24M-2.05M-1.57M-1.81M-1.34M-1.63M-1.37M-1.75M-1.64M-1.85M-2.05M-2.08M-2.54M-2.09M-2.05M-2.35M-2.75M
Income from Continuing Operations (Quarter) -0.75M-1.03M-1.24M-2.05M-11.85M-12.54M-12.43M-1.63M-13.35M-13.95M-14.30M-1.90M-15.68M-16.05M-16.96M-2.10M-17.34M-2.35M-2.76M
Consolidated Net Income (Quarter) -0.75M-1.03M-1.24M-2.05M-11.85M-12.54M-12.43M-1.63M-13.35M-13.95M-14.30M-1.90M-15.68M-16.05M-16.96M-2.10M-17.34M-2.35M-2.76M
Income towards Parent Company (Quarter) -0.75M-1.03M-1.24M-2.05M-11.85M-12.54M-12.43M-1.63M-13.35M-13.95M-14.30M-1.90M-15.68M-16.05M-16.96M-2.10M-17.34M-2.35M-2.76M
Net Income towards Common Stockholders (Quarter) -0.75M-1.03M-1.24M-2.05M-11.85M-12.54M-12.43M-1.63M-13.35M-13.95M-14.30M-1.90M-15.68M-16.05M-16.96M-2.10M-17.34M-2.35M-2.76M
Additional items
EPS (Basic) (Quarter) -22.69-31.23-37.29-61.91-209.96-152.77-150.87-20.53-129.19-127.54-26.59-5.39-20.17-17.49-17.20-2.24-13.30-0.85-1.05
EPS (Diluted) (Quarter) -22.69-31.23-37.29-61.91-209.96-152.77-150.87-20.53-129.19-127.54-26.59-5.39-20.17-17.49-17.20-2.24-13.30-0.85-0.99
Shares Outstanding (Quarter) 0.03M0.03M0.03M0.03M0.06M0.08M0.08M0.08M0.10M0.11M0.54M0.35M0.78M0.92M0.99M0.94M1.30M2.78M2.78M2.63M
Shares Outstanding (Diluted) (Quarter) 0.03M0.03M0.03M0.03M0.06M0.08M0.08M0.08M0.10M0.11M0.54M0.35M0.78M0.92M0.99M0.94M1.30M2.78M2.78M2.78M
Shares Outstanding (Entity) (Quarter) 0.03M0.03M0.03M0.03M0.06M0.08M0.08M0.08M0.11M0.11M0.64M0.35M0.91M0.95M1.03M1.12M1.30M3.07M2.63M
EBITDA (Quarter) -0.67M-0.96M-1.10M-1.98M-1.43M-1.77M-1.31M-1.60M-1.33M-1.57M-1.53M-1.88M-2.08M-1.99M-2.37M-1.92M-1.87M-2.07M-2.54M
Interest Expenses (Quarter) 0.08M0.08M0.14M0.08M10.42M10.77M11.12M0.03M12.02M12.38M12.78M0.02M13.61M14.06M14.59M0.18M15.46M0.28M0.23M